Jump Trading’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Jump Trading’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-18	Closed	-$1.01M	–	894
2015 Q3	$1.01M	Buy	+18	New	+$13.2K	0.01%	171

Other funds holding TTPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jump Trading's TTPH Position: Q3 2018 in Review

Jump Trading sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2018, closing a stake of 570 shares — an estimated $41K sold.

Jump Trading first reported a position in TTPH in Q3 2015 and held it in 2 quarters. The position peaked at $1.04M in Q3 2015. 92 funds tracked by Wall St. Rank hold TTPH as of Q3 2018.

Jump Trading reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
Jump Trading sold 570 Tetraphase Pharmaceuticals, Inc. shares in Q3 2018, an estimated $41K.
Jump Trading first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2015 and held it in 2 quarters.
Jump Trading's Tetraphase Pharmaceuticals, Inc. position peaked at $1.04M in Q3 2015.
92 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2018.

Based on Jump Trading's 13F filing for Q3 2018, filed 14 Nov 2018.